Literature DB >> 21693709

Exciting new clinical trials in cystic fibrosis: infants need not apply.

Stephen M Stick, Peter David Sly.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21693709     DOI： 10.1164/rccm.201102-0251ED

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  4 in total

1.  Future directions in early cystic fibrosis lung disease research: an NHLBI workshop report.

Authors:  Bonnie W Ramsey; Susan Banks-Schlegel; Frank J Accurso; Richard C Boucher; Garry R Cutting; John F Engelhardt; William B Guggino; Christopher L Karp; Michael R Knowles; Jay K Kolls; John J LiPuma; Susan Lynch; Paul B McCray; Ronald C Rubenstein; Pradeep K Singh; Eric Sorscher; Michael Welsh
Journal:  Am J Respir Crit Care Med       Date:  2012-02-03       Impact factor: 21.405

Review 2.  Early Lung Disease in Infants and Preschool Children with Cystic Fibrosis. What Have We Learned and What Should We Do about It?

Authors:  Sarath C Ranganathan; Graham L Hall; Peter D Sly; Stephen M Stick; Tonia A Douglas
Journal:  Am J Respir Crit Care Med       Date:  2017-06-15       Impact factor: 21.405

3.  Hypertonic saline is effective in the prevention and treatment of mucus obstruction, but not airway inflammation, in mice with chronic obstructive lung disease.

Authors:  Simon Y Graeber; Zhe Zhou-Suckow; Jolanthe Schatterny; Stephanie Hirtz; Richard C Boucher; Marcus A Mall
Journal:  Am J Respir Cell Mol Biol       Date:  2013-09       Impact factor: 6.914

4.  Airway gene transfer in a non-human primate: lentiviral gene expression in marmoset lungs.

Authors:  N Farrow; D Miller; P Cmielewski; M Donnelley; R Bright; D W Parsons
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.